EPD Stock Recent News

Inflation isn't just back, it's becoming policy. From skewed CPI data to deficit-driven dollar moves, we're entering a new and lasting macro era. The U.S. may now prefer higher inflation to fix its balance sheet and boost growth. That changes everything, including how we invest, where we invest, and why. I'm not overhauling my strategy. But I'm sharpening my focus on pricing power, hard assets, and income that's built for this new reality.

Investors love dividend stocks, especially the blue-chip variety, because they offer a significant income stream and have massive total return potential.

High yield, high conviction blue-chip stocks are invaluable for both income and value investors. I share two of my top picks for H2 2025. I also share some of the risks facing them.

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before, potentially resulting in a 15% CAGR in FreeStyle Libre sales by 2028. With Abbott acquiring rights to 4 more biosimilar products and a double-digit CAGR in the target biosimilar emerging markets, the EPD business could stimulate EPS growth beyond Medical Devices. With an excellent balance sheet and over 50 consecutive years of dividend increases, Abbott is a robust long-term investment for income investors.

Oil and natural gas prices can move in unexpected ways and do so in a dramatic and rapid fashion. The geopolitical conflicts playing out today are yet another evidence point that energy investors need to be prepared to deal with often headline-grabbing and perhaps shocking volatility.

Dividend stocks not only offer a regular stream of passive income but are also proven wealth-builders, especially if you invest in top-notch dividend growth stocks and reinvest the dividends. Doing so could even earn you monstrous returns over time due to the power of compounding.

Buy, sell, or hold? That's the question investors must continually ask about each stock in their portfolio.

If you are looking at Kinder Morgan (KMI 0.26%) and its 4.1% dividend yield, you should also consider Enterprise Products Partners (EPD -0.06%) and its 6.8% distribution yield. But the reason for preferring Enterprise over Kinder Morgan is only partly to do with the yield, particularly if you are a dividend-focused investor.

I have a confession to make. I'm much more interested in dividend stocks than I've ever been before.

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.